RBC Life Sciences, Inc. | ||||||||
Condensed Balance Sheets | ||||||||
(in thousands) | ||||||||
(unaudited) | ||||||||
June 30, | December 31, | |||||||
2010 | 2009 | |||||||
| Assets | ||||||||
| Cash and cash equivalents | $ | 3,697 | $ | 3,972 | ||||
| Inventories | 4,804 | 5,344 | ||||||
| Other current assets | 2,002 | 1,914 | ||||||
| Total current assets | 10,503 | 11,230 | ||||||
| Other assets | 7,207 | 7,383 | ||||||
| Total assets | $ | 17,710 | $ | 18,613 | ||||
| Liabilities and shareholders' equity | ||||||||
| Accounts payable and accrued liabilities | $ | 2,444 | $ | 2,729 | ||||
| Deferred revenue | 2,715 | 3,669 | ||||||
| Other current liabilities | 163 | 156 | ||||||
| Total current liabilities | 5,322 | 6,554 | ||||||
| Other liabilities | 2,758 | 2,840 | ||||||
| Shareholders' equity | 9,630 | 9,219 | ||||||
| Total liabilities and shareholders' equity | $ | 17,710 | $ | 18,613 | ||||
